StockData
Iambic Therapeutics, Inc. logo

Iambic Therapeutics, Inc. (IAM) company profile

IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$13.10−1.74 (-11.73%)

Close on Nov 13, 2026Market cap –P/E –Yield –

About Iambic Therapeutics

Biological Products, (No Diagnostic Substances), SIC 2836

Iambic Therapeutics, Inc. is listed on Nasdaq under the ticker IAM, in the SEC industry Biological Products, (No Diagnostic Substances). It is incorporated in Delaware and its fiscal year ends on December 31.

Company profile

Company

Legal name
Iambic Therapeutics, Inc.
Headquarters
San Diego, CA
Address
5627 Oberlin Drive, Suite 120 92121
Phone
(626) 592-2520
Website
iambic.ai
Industry
Biological Products, (No Diagnostic Substances)
Incorporated in
Delaware
Fiscal year ends
December 31

Stock & identifiers

Ticker
IAM
Exchange
Nasdaq
IPO date
Oct 15, 2026
SEC CIK
1997038
CUSIP
45076A101
ISIN
US45076A1016
FIGI
BBG011RJ5Z57
Share class FIGI
BBG011RJ5Z66
EIN
84-3364168

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Frederick R. ManbyChief Technology Officer, Director1,862,665
Thomas F. MillerChief Executive Officer, Director1,410,756
Michael SecoraCFO & Chief Corp Dev Ofcr279,902
Peter A. OlsonChief Scientific Officer30,909
Neil JosephsonChief Medical Officer71,459
William H. RastetterDirector200,920
R. Jacob VogelsteinDirector742,546
Evan Lockwood RachlinDirector57,754
Kurt Von EmsterDirector–
Shalini SharpDirector–
Mary TagliaferriDirector–
Samit HirawatDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Oct 15, 2026
Offer price
$16.00
Securities offered
9,375,000
Gross proceeds
$150.00M
Exchange
Nasdaq
First trading day
Oct 15, 2026
First-day close
$18.91+18.2%
Lock-up ends (est.)
Apr 13, 2027

“The initial public offering price is $16.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?